| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Liquidia Corp | Director, Other*, 10%+ Owner | Common Stock, $0.001 par value per share ("Common Stock") | 11,280,945 | $80,771,566 | $7.16 | 14 Dec 2023 | Indirect |
| Liquidia Corp | Director, Other*, 10%+ Owner | Common Stock, $0.001 par value per share ("Common Stock") | 8,118,592 | $72,255,469 | $8.90 | 12 Sep 2024 | Indirect |
| STANDARD BIOTOOLS INC. | 10%+ Owner | Common Stock | 7,797,454 | $19,805,533 | $2.54 | 03 Jul 2023 | Indirect |
| STANDARD BIOTOOLS INC. | 10%+ Owner | Common Stock, $0.001 par value per share ("Common Stock") | 8,467,920 | $14,734,181 | $1.74 | 29 Jun 2023 | Indirect |
| Verrica Pharmaceuticals Inc. | Other* | Common Stock, par value $0.0001 per share ("Common Stock") | 923,910 | $6,199,436 | $6.71 | 26 Dec 2025 | Indirect |
| Liquidia Corp | Director, Other*, 10%+ Owner | Common Stock | 20,359 | $181,195 | $8.90 | 12 Sep 2024 | Direct |
| ALIMERA SCIENCES INC | 10%+ Owner | Common Stock, par value $0.01 per share ("Common Stock") | 0 | $0 | $3.83 | 16 Sep 2024 | Indirect |
| ALIMERA SCIENCES INC | 10%+ Owner | Notional Derivative Agreements (obligation to buy) | 0 | 16 Sep 2024 | Indirect | ||
| ALIMERA SCIENCES INC | 10%+ Owner | Warrants | 0 | 16 Sep 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | 26 Dec 2025 | 0 | $0 | 3 | Other* | 30 Dec 2025, 07:08 |
| /report/000090266424005552-caligan-partners-lp-2024-09-16 | ALIMERA SCIENCES INC | 16 Sep 2024 | 3 | $0 | 4 | 10%+ Owner | 18 Sep 2024, 16:30 |
| LQDA | Liquidia Corp | 12 Sep 2024 | 1 | +$9,999,996 | 4 | Director, Other*, 10%+ Owner | 12 Sep 2024, 16:31 |
| LQDA | Liquidia Corp | 30 Aug 2024 | 3 | $0 | 4 | Director, Other*, 10%+ Owner | 04 Sep 2024, 17:51 |
| LQDA | Liquidia Corp | 14 Dec 2023 | 1 | +$7,999,997 | 4 | Director, Other*, 10%+ Owner | 14 Dec 2023, 16:42 |
| /report/000090266423004790-caligan-partners-lp-2023-09-14 | ALIMERA SCIENCES INC | 14 Sep 2023 | 3 | $0 | 4 | 10%+ Owner | 15 Sep 2023, 17:05 |
| /report/000090266423004504-caligan-partners-lp-2023-08-15 | ALIMERA SCIENCES INC | 15 Aug 2023 | 4 | +$28,975,745 | 4 | 10%+ Owner | 17 Aug 2023, 20:01 |
| /report/000090266423004387-caligan-partners-lp-2023-08-01 | ALIMERA SCIENCES INC | 01 Aug 2023 | 0 | $0 | 3 | 10%+ Owner | 11 Aug 2023, 17:00 |
| LAB | STANDARD BIOTOOLS INC. | 29 Jun 2023 | 2 | $0 | 4 | 10%+ Owner | 03 Jul 2023, 17:18 |
| LAB | STANDARD BIOTOOLS INC. | 29 Dec 2022 | 1 | $0 | 4 | 10%+ Owner | 30 Dec 2022, 16:16 |
| LQDA | Liquidia Corp | 06 Sep 2022 | 1 | +$1,405,000 | 4 | Director, Other*, 10%+ Owner | 07 Sep 2022, 09:15 |
| LAB | STANDARD BIOTOOLS INC. | 03 Aug 2022 | 2 | +$526,608 | 4 | 10%+ Owner | 05 Aug 2022, 11:10 |
| LAB | STANDARD BIOTOOLS INC. | 29 Jul 2022 | 3 | +$953,650 | 4 | 10%+ Owner | 02 Aug 2022, 17:27 |
| LAB | STANDARD BIOTOOLS INC. | 13 Jun 2022 | 1 | +$170,000 | 4 | Other*, 10%+ Owner | 15 Jun 2022, 09:06 |
| LAB | STANDARD BIOTOOLS INC. | 02 Jun 2022 | 2 | +$879,000 | 4 | 10%+ Owner | 06 Jun 2022, 14:01 |
| LQDA | Liquidia Corp | 25 May 2022 | 1 | +$269,960 | 4 | Director, Other*, 10%+ Owner | 26 May 2022, 08:47 |
| LQDA | Liquidia Corp | 17 May 2022 | 3 | +$1,301,473 | 4 | Director, Other*, 10%+ Owner | 19 May 2022, 18:16 |
| LAB | STANDARD BIOTOOLS INC. | 06 May 2022 | 2 | +$1,406,715 | 4 | 10%+ Owner | 10 May 2022, 21:03 |
| LAB | STANDARD BIOTOOLS INC. | 28 Apr 2022 | 3 | +$1,075,574 | 4 | 10%+ Owner | 02 May 2022, 19:44 |
| LQDA | Liquidia Corp | 18 Apr 2022 | 1 | +$8,999,996 | 4 | Director, Other*, 10%+ Owner | 18 Apr 2022, 18:29 |
| LAB | STANDARD BIOTOOLS INC. | 11 Apr 2022 | 2 | +$741,150 | 4 | 10%+ Owner | 13 Apr 2022, 16:27 |
| LAB | STANDARD BIOTOOLS INC. | 06 Apr 2022 | 3 | +$1,922,463 | 4 | 10%+ Owner | 08 Apr 2022, 17:19 |
| LAB | FLUIDIGM CORP | 07 May 2021 | 0 | $0 | 3 | 10%+ Owner | 10 May 2021, 16:30 |